Advancing Pharmaceutical Innovation: Brains Bioceutical's CEP Certification will Streamline Cannabinoid Drug Development, Inspired by Jazz Pharmaceuticals' CBD-Based Epilepsy Drug and 2024 $1.4 Billio......
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) - Olaplex Holdings, Inc. (“OLAPLEX”), today announced their participation in the Barclays 17th Annual Global Consumer Staples Conference in Boston, MA.
Japan Tobacco Inc. (JT) (the “Company”) (TSE: 2914) announces today that the JT Group has reached an agreement with Vector Group Ltd. (“VGR”), the fourth largest toba......
